<div id="readability-page-1"><ul><li>Eli Lilly’s New Drug Data Sets Up a High-Stakes 2026</li></ul><p>Eli Lilly and Company, Novo Nordisk A/S,  and Pfizer are the three Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are equity shares of companies that research, develop, manufacture, and sell prescription drugs, biologics, and vaccines. For investors, they tend to carry high R&amp;D and regulatory risk and are driven by clinical trial results, approvals and patent timelines, which can produce significant upside or volatility. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.</p><div><p><span></span><span>Get <strong>Eli Lilly and Company</strong> alerts:</span></p></div><h2>Eli Lilly and Company (LLY)</h2><p>Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.</p><ul><li>Sector Rotation: 2 Smart Money Moves for 2026</li></ul><p>Read Our Latest Research Report on LLY</p><h2>Novo Nordisk A/S (NVO)</h2><p>Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.</p><ul><li>3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most</li></ul><p>Read Our Latest Research Report on NVO</p><h2>Pfizer (PFE)</h2><p>Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands.</p><p>Read Our Latest Research Report on PFE</p><h2>Recommended Stories</h2><ul><li>MarketBeat's Top Five Stocks to Own in December 2025</li><li>The Toro Company: A Baby Bull Market Is Gaining Traction</li><li>Netflix Is Out of Favor—and That’s Why It’s Getting Interesting</li><li>Gold and Silver Exploded—Now Copper May Be the Next Big Trade</li><li>Fresh Air, Fresh Highs: 3 Premium Outdoor Brands with 2026 Tailwinds</li><li>MarketBeat Week in Review – 12/22 - 12/26</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Eli Lilly and Company Right Now?</h2><p>Before you consider Eli Lilly and Company, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.</p><p>While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>MarketBeat highlights Eli Lilly, Novo Nordisk, and Pfizer as top pharmaceutical stocks to watch. These companies are involved in developing and selling drugs and vaccines, with high R&D and regulatory risks. Eli Lilly focuses on diabetes and obesity treatments, Novo Nordisk on diabetes and rare diseases, and Pfizer on various therapeutic areas including COVID-19. Despite Eli Lilly's moderate buy rating, top analysts suggest other stocks as better buys. The report emphasizes the potential volatility and upside in pharmaceutical investments.</p>

- Eli Lilly, Novo Nordisk, and Pfizer are highlighted as top pharmaceutical stocks based on recent trading volume and market interest.  
- These companies engage in the research, development, and sale of drugs with substantial R&D and regulatory risks, influenced by clinical trial outcomes and patent timelines.  
- The article emphasizes that while Eli Lilly has a Moderate Buy rating, other stocks may offer better investment opportunities according to analysts.

Top Pharmaceutical Stocks To Follow Now - December 28th